Drs Ursula A. Matulonis and Gini F. Fleming discuss the state of endometrial cancer, the role of immunotherapy, and priorities for research in this field.

A retrospective study showed that either folate receptor alpha or B7-H4 was expressed in more than 80% of endometrial cancers ...

Dual checkpoint inhibitors led to longer overall survival in patients with high-risk endometrial cancer who displayed ...

Sensitivity was 95% for type 2 endometrial cancers (serous carcinoma, clear cell carcinoma, and carcinosarcoma) but fell to 36% for atypical hyperplasia. Additional studies are underway to further ...

Zentalis Pharmaceuticals, Inc.’s ZNTL share price has dipped by 8.97%, which has investors questioning if this is right time ...

The safety and efficacy of dostarlimab plus chemotherapy in patients with advanced endometrial cancer were confirmed by ...

Inquirer reporter Julie Alipala, who spent decades covering conflicts and peace-building efforts in Mindanao, died early ...

In late 2024, she was diagnosed with endometrial cancer with serous carcinoma and had been undergoing post-surgery treatment. Five days ago, she was hospitalized due to breathing difficulties.

"We previously identified endometrial cancer as a sensitive tumor type with our AP3 platform ... with aggressive histopathologies (75% serous or carcinosarcomas), pMMR, and p53 mutations, we observed ...

“We previously identified endometrial cancer as a sensitive tumor type with ... with aggressive histopathologies (75% serous or carcinosarcomas), pMMR, and p53 mutations, we observed strong ...